23 related articles for article (PubMed ID: 14534946)
1. The development of bone metastases as the first sign of metastatic spread in patients with primary solid tumours.
Papadakis SA; Mitsitsikas TC; Markakidis S; Minas MK; Tripsiannis G; Tentes AA
Int Orthop; 2004 Apr; 28(2):102-5. PubMed ID: 15224168
[TBL] [Abstract][Full Text] [Related]
2. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?].
Ruiz de la Roja JC; Llorente Abarca C; Romero Cagigal I; Páez Borda A; Fernández González I; Martín Osés E; Berenguer Sánchez A
Actas Urol Esp; 1995 Feb; 19(2):123-7. PubMed ID: 7539572
[TBL] [Abstract][Full Text] [Related]
3. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
Gleave ME; Coupland D; Drachenberg D; Cohen L; Kwong S; Goldenberg SL; Sullivan LD
Urology; 1996 May; 47(5):708-12. PubMed ID: 8650870
[TBL] [Abstract][Full Text] [Related]
4. Bone scan can be spared in asymptomatic prostate cancer patients with PSA of <=20 ng/ml and Gleason score of <=6 at the initial stage of diagnosis.
Tanaka N; Fujimoto K; Shinkai T; Nakai Y; Kuwada M; Anai S; Miyake M; Hirayama A; Hasegawa M; Hirao Y
Jpn J Clin Oncol; 2011 Oct; 41(10):1209-13. PubMed ID: 21862505
[TBL] [Abstract][Full Text] [Related]
5. Which patients with prostatic carcinoma require a staging bone scan?
Kemp PM; Maguire GA; Bird NJ
Br J Urol; 1997 Apr; 79(4):611-4. PubMed ID: 9126094
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
Wolff JM; Bares R; Jung PK; Buell U; Jakse G
Urol Int; 1996; 56(3):169-73. PubMed ID: 8860738
[TBL] [Abstract][Full Text] [Related]
7. Baseline staging of newly diagnosed prostate cancer: a summary of the literature.
Abuzallouf S; Dayes I; Lukka H
J Urol; 2004 Jun; 171(6 Pt 1):2122-7. PubMed ID: 15126770
[TBL] [Abstract][Full Text] [Related]
8. The assessment of treatment outcomes in metastatic prostate cancer: changing endpoints.
Dawson NA; McLeod DG
Eur J Cancer; 1997 Apr; 33(4):560-5. PubMed ID: 9274435
[No Abstract] [Full Text] [Related]
9. Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.
Lawrentschuk N; Davis ID; Bolton DM; Scott AM
Int J Urol; 2007 Feb; 14(2):89-95. PubMed ID: 17302562
[TBL] [Abstract][Full Text] [Related]
10. Current approaches to prostate cancer.
O'Brien WM; Lynch JH
Hosp Pract (Off Ed); 1988 Jan; 23(1):143-5, 149-50, 155 passim. PubMed ID: 3121651
[No Abstract] [Full Text] [Related]
11. Bone scan in initial staging of prostate cancer.
Boughattas S; Letaief B; Hassine H; Chatti K; Essabah H
Tunis Med; 2003 Jun; 81(6):400-6. PubMed ID: 14534946
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
